Last reviewed · How we verify
NCT04307563
Effects of Mindfulness Training on Burnout and Mood in Hospital Employees
NA trial testing Mindfulness session in Anxiety Depression in 52 participants. Completed in 5 July 2022.
5 July 2022
Quick facts
| Lead sponsor | Stanford University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | other |
| Enrollment | 52 |
| Start date | 1 September 2021 |
| Primary completion | 5 July 2022 |
| Estimated completion | 5 July 2022 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Mindfulness session
Conditions studied
- Anxiety Depression — all drugs for Anxiety Depression →
- Burnout — all drugs for Burnout →
Sponsor
Stanford University
Who can join
18 and older, any sex, with Anxiety Depression or Burnout. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The primary aims of the study are to 1) provide a hospital employee population with a mindfulness based stress reduction workshop and 2) evaluate the impact of this clinically validated group mindfulness intervention on burnout in health care employees. Secondary outcomes will be anxiety, depression, quality of life and self compassion.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04307563
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Mindfulness session
Trials testing the same drug.
- NCT04518085 — Psychological Interventions to Prevent Late Effects in Breast Cancer · NA · completed
Other recruiting trials for Anxiety Depression
Currently open trials in the same condition.
- NCT07136584 — SOS for Caregiver Wellbeing · NA · recruiting
- NCT07151573 — Evaluating the Big Five Intervention in Norway · NA · recruiting
- NCT07089914 — Health Surveillance at University of Applied Science Hamburg (HAW) · active not recruiting
- NCT06770517 — Exposure Therapy for Late-life Anxiety · NA · recruiting
- NCT06441786 — A Metacognitive Group Therapy of Depression and Anxiety in Youth With Autism · NA · recruiting
Other Stanford University trials
Trials by the same sponsor.
- NCT05945147 — Ketamine and Midazolam Infusions for CRPS: Feasibility Study · Phase 2 · withdrawn
- NCT04225949 — Patients Understanding of PROM Graphs · NA · withdrawn
- NCT06273098 — School-Based Bladder Health Intervention · NA · withdrawn
- NCT04652635 — Management of Nailbed Injuries · NA · withdrawn
- NCT05443503 — Stanford Spine Keeper - Managing Your Low Back Pain · NA · suspended
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04307563 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Stanford University
- Last refreshed: 12 December 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04307563.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing